Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Shinjo Ophthalmologic Institute |
---|---|
Information provided by: | Shinjo Ophthalmologic Institute |
ClinicalTrials.gov Identifier: | NCT00685490 |
To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occlusion (BRVO).
Results suggest the following hypothesis:
Condition | Intervention |
---|---|
Vitrectomy |
Procedure: Vitrectomy w/o ILM peeling for macular edema with BRVO |
Study Type: | Observational |
Study Design: | Case-Only, Retrospective |
Official Title: | Vitrectomy for Persistent Macular Edema in Branch Retinal Vein Occlusion |
Enrollment: | 70 |
Study Start Date: | July 1995 |
Study Completion Date: | November 2006 |
Groups/Cohorts | Assigned Interventions |
---|---|
Surgical
Retrospective chart review of 70 eyes of 70 consecutive patients who underwent PPV, with and without ILM peeling, for persistent macular edema associated with BRVO
|
Procedure: Vitrectomy w/o ILM peeling for macular edema with BRVO
Concurrent phacoemulsification and intraocular lens insertion in the capsular bag was performed, followed by PPV with separation of the posterior hyaloid from the optic disk and posterior retina with a posterior vitreous detachment was not present. Indocyanine green (ICG)-assisted peeling was performed in all consecutive patients between April 2000 and June 2003. 0.1% ICG solution was injected over the macular region. Immediately after application, the dye was washed out using a vitreous cutter. Repeated injection of ICG was not required. Triamcinolone acetonide (TA)-assisted ILM peeling was performed in all consecutive patients from July 2003 to November 2006.
|
Ages Eligible for Study: | 45 Years to 86 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
70 consecutive patients who underwent PPV, with and without OLM peeling, for persistent macular edema associted with BRVO
Inclusion Criteria:
Exclusion Criteria:
Japan | |
Shinjo Ophthalmologic Institute | |
Miyazaki, Japan, 880-0035 |
Principal Investigator: | Kazuyuki Kumagai, MD | Shinjo Ophthalmologic Institute |
Responsible Party: | Shinjo Ophthalmologic Institute ( Kazuyuki Kumagai ) |
Study ID Numbers: | KK-R-207-430R1, Kumagai BRVO |
Study First Received: | May 22, 2008 |
Last Updated: | May 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00685490 |
Health Authority: | Japan: Institutional Review Board |
branch retinal vein occlusion internal limiting membrane macular edema vitrectomy |
Eye Diseases Vascular Diseases Edema Triamcinolone diacetate Thrombosis Triamcinolone hexacetonide Macular Edema |
Embolism and Thrombosis Triamcinolone Acetonide Embolism Retinal Vein Occlusion Triamcinolone Venous Thrombosis Retinal Diseases |
Cardiovascular Diseases |